Black Diamond Therapeutics
BDTX
BDTX
109 hedge funds and large institutions have $915M invested in Black Diamond Therapeutics in 2020 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
+21
Holders Change %
+23.86%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
33
Increased
43
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.4M |
| 2 |
BlackRock
New York
|
+$18.5M |
| 3 |
State Street
Boston,
Massachusetts
|
+$17.4M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$10.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.46M |
Top Sellers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$4.4M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.08M |
| 3 |
SG Americas Securities
New York
|
-$1.27M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$817K |
| 5 |
TC
Telemus Capital
Southfield,
Michigan
|
-$506K |
